The Yangtze River Delta Advanced Medical Technology Innovation Center, located in Taixing, Jiangsu province, recently attracted wide attention, as its first industrial incubation project – the oral micro nano iron oxide assembly project, is expected to put China on the map in intestinal targeted therapy.
This globally pioneering technology has been in development for a decade, boasts strong biocompatibility and can regulate intestinal microbiota metabolism. It provides new treatment ideas for neurological hearing loss, tumors and other diseases.
The Yangtze River Delta Advanced Medical Technology Innovation Center. [Photo/WeChat account: txfabu]
The center is the sole technological innovation hub in the biopharmaceutical field established by the Shanghai-based National Innovation Center par Excellence, or NICE.
Gu Ning, academician of the Chinese Academy of Sciences, is the center's chief scientist.
By promoting the development of various innovative projects, the center is continuously exploring cutting-edge technologies in biomedicine and accelerating the transformation and application of scientific research achievements.
In the future, the center will continue to leverage its platform advantages and expand into the field of metabolic disease treatment, helping Taixing build a mecca of biomedical innovation.
A researcher conducts an experiment at the center. [Photo/WeChat account: txfabu]